Centella Mauritius Holdings, a special purpose investment vehicle controlled by affiliates of TPG Inc., executed a significant block deal on Wednesday, August 19, selling 5.81 crore shares or 6.66% equity in Aster DM Quality Care worth ₹4,451.45 crore. According to latest reports from The Hindu BusinessLine and CNBC TV18, this represents a substantial divestment by the private equity firm from India's largest integrated healthcare provider. The transaction follows the merger of Aster DM Healthcare with Quality Care India Limited, creating a combined entity. As per The Hindu BusinessLine, the shares were disposed of at an average price of ₹766.17 per equity share, with the shares changing hands at ₹766.1 per share during the block deal. This transaction has significantly reduced TPG's holding from 9.9% as of June 2026 to 3.24% post the stake sale.
Following the block deal announcement, Aster DM Quality Care witnessed extraordinary trading activity with volume surging to much higher-than-average levels on the National Stock Exchange, with the stock declining nearly 4% to ₹771.05 on August 20, as reported by The Hindu BusinessLine. The stock had a gap-down opening post the big stake sale by Centella, reflecting immediate market reaction to the transaction news. The company now trades at a market capitalisation of ₹67,519.7 crore, demonstrating strong investor interest despite the significant stake sale by the private equity firm. According to The Hindu BusinessLine, the heavy supply from a large shareholder has weighed on the stock in Thursday's session, with the stock under pressure for a month now, losing over 5.22% during the period.
Four domestic and global institutional investors acquired little more than half of the shares worth ₹2,287.63 crore sold by Centella during the transaction. According to The Hindu BusinessLine and CNBC TV18, HDFC Mutual Fund emerged as the biggest buyer, acquiring additional 1.5 crore shares representing 1.72% of paid-up equity for ₹1,149.9 crore at the same price of ₹766.1 per share. Kotak Mahindra Mutual Fund also picked up 45.68 lakh shares (0.52% stake) for ₹349.95 crore, while Integrated Core Strategies Asia bought 49.94 lakh shares for ₹382.6 crore and Citigroup Global Markets Singapore purchased 52.88 lakh shares for ₹405.11 crore at the same price. As per The Hindu BusinessLine, these entities together acquired 2,98,60,469 equity shares, amounting to a 3.42% stake in the company. As per Moneycontrol, HDFC MF and Kotak Mahindra MF held 5.19% and 2.84% shares respectively in the company as per the June 2026 shareholding pattern.
On August 19, Catalyst Trusteeship Limited, acting as the Indian security agent for certain lenders to Centella Mauritius Holdings, disclosed the creation of a pledge over additional Aster DM Quality Care shares. The filing revealed that 7.98 crore additional shares had been pledged following the merger of Aster DM Healthcare and Quality Care India Limited, representing about 9.2% of the resulting company's paid-up share capital. Including the earlier pledge, the total encumbered holding stood at 8.44 crore shares, or about 9.7% of Aster DM Quality Care's equity. This disclosure provides additional context around Centella's holding structure and the financial obligations backing the stake sale.
Aster DM Quality Care reported a consolidated net profit of ₹16.1 crore for Q1 FY2027, compared with ₹85.5 crore in the corresponding period last year, marking an 81.2% year-on-year decline. However, the company demonstrated strong operational performance with revenue from operations rising 21.6% year-on-year to ₹1,311 crore from ₹1,078 crore a year earlier. At the operating level, EBITDA increased 27.5% to ₹264.3 crore from ₹207.4 crore in the year-ago period, with EBITDA margin improving to 20.2% from 19.2%, reflecting better operating efficiency. The company has significantly outperformed the benchmark Nifty 50, gaining 35% in 2026 compared to an 8% decline in the Nifty 50, with the stock advancing 33% over the past year versus a 3.7% decline in the benchmark index. Currently trading at a price-to-earnings multiple of 192.25 times, the stock continues to demonstrate strong long-term fundamentals despite recent selling pressure.
